Co-sedative during brain tumor anaesthesia

Lidocaine versus magnesium sulphate infusion during isoflurane brain tumor anaesthesia, effect on minimum alveolar concentration reduction guided by bispectral index: prospective randomized controlled trial.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202007774954789

Enrollment

Registered

2020-07-17

Start date

2020-07-04

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

magnesium sulphate infusion

lidocaine infusion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: adults both sex ASA I or II aging 18-65 years undergoing supra tenttorial brain tumor surgery in mansoura university hospitals.

Exclusion criteria

Exclusion criteria: 1-Patient refusal 2-Major cardiopulmonary disorders 3-Hepatic or renal disorders 4-Allergy to used drugs.

Design outcomes

Primary

Measure	Time frame
minimum alveolar concentration reduction	—

Secondary

Measure	Time frame
richmond agitation sedation scale;VAS score;total muscle relaxant dose, recovery time;HR, MABP, Spo2, end tidal Co2 , bispectral index	—

Countries

Egypt

Contacts

Public Contactmohamed aboelela

lecturer of anaesthesia and SICU

aboelela_mohamed@yahoo.com00201061546753

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026